Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine Monotherapy vs Adjunct to Lithium in Acute Mania
NCT00672490Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of quetiapine (extended-release tablet, brand name: Bipresso) in bipolar I disorder (2 arms), sponsored by AstraZeneca. Primary endpoint: Change in the Young Mania Rating Scale Total Score at 4 weeks. Started Apr 2008; status: completed.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00672490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00672490.